menu
    • menu
    [{"orgOrder":0,"company":"Olpha","sponsor":"Not Applicable","pharmaFlowCategory":"D","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Small molecule","year":"2021","type":"Agreement","leadProduct":"Furazidin","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Olpha","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Tablet","sponsorNew":"Olpha \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Olpha \/ Not Applicable"},{"orgOrder":0,"company":"Silvanols","sponsor":"Not Applicable","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Small molecule","year":"2020","type":"Not Applicable","leadProduct":"Olea Europea Extract","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Silvanols","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Silvanols \/ Not Applicable","highestDevelopmentStatusID":"12","companyTruncated":"Silvanols \/ Not Applicable"},{"orgOrder":0,"company":"Silvanols","sponsor":"University of Lorraine","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Small molecule","year":"2020","type":"Not Applicable","leadProduct":"Crocus Sativus","moa":"","graph1":"Neurology","graph2":"Approved","graph3":"Silvanols","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Silvanols \/ University of Lorraine","highestDevelopmentStatusID":"12","companyTruncated":"Silvanols \/ University of Lorraine"},{"orgOrder":0,"company":"Silvanols","sponsor":"University of Latvia","pharmaFlowCategory":"DU","therapeuticArea":"Infections and Infectious Diseases","country":"","productType":"Small molecule","year":"2021","type":"Not Applicable","leadProduct":"Olea Europea","moa":"","graph1":"Infections and Infectious Diseases","graph2":"Approved","graph3":"Silvanols","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Infectious Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Silvanols \/ University of Latvia","highestDevelopmentStatusID":"12","companyTruncated":"Silvanols \/ University of Latvia"}]

    Find Clinical Drug Pipeline Developments & Deals by Olpha

    Menu

    Olpha

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Olpha

                            Latvia
                            2024 ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothOlpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.

                            Lead Product(s) : Furazidin

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Approved

                            Sponsor : Not Applicable

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            DEALS_DEV arrow-down

                            JSC Olainfarm & Adalvo to Launch a New Urology Product in 17 Countries In 2022-2023

                            Details : In partnership Olainfarm will manage Furagins (Furaginum) regulatory affairs, distribution and promotion in Latvia, Russia, Kazakhstan, Belarus, Ukraine, and other countries and Adalvo will be responsible for development, manufacturing and will support m...

                            Brand Name : Furagins

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            June 16, 2021

                            Lead Product(s) : Furazidin

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Approved

                            Sponsor : Not Applicable

                            Deal Size : Undisclosed

                            Deal Type : Agreement

                            Olpha

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Silvanols

                            Latvia
                            2024 ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tabebuia Avellandae,Olea Europea,Zinc Glycinate

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Approved

                            Sponsor : University of Latvia

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            DEALS_DEV arrow-down

                            Latvia Can! A New Remedy for Respiratory Diseases Created and Researched!

                            Details : Goimmune Strong contains bark extract of pink tabebuia, olive leaf extract, brazilian green propolis, zinc bisglycinate and organic selenium. It promotes the protection of cells against oxidative stress and showed antibacterial activity in respiratory di...

                            Brand Name : Goimmune Strong

                            Molecule Type : Small molecule

                            Upfront Cash : Not Applicable

                            February 02, 2021

                            Lead Product(s) : Tabebuia Avellandae,Olea Europea,Zinc Glycinate

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Approved

                            Sponsor : University of Latvia

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            Silvanols

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            Silvanols

                            Latvia
                            2024 ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Lactium,Ginseng Extract,Crocus Sativus

                            Therapeutic Area : Neurology

                            Study Phase : Approved

                            Sponsor : University of Lorraine

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            DEALS_DEV arrow-down

                            Silvanols Launches the First Combined Product in Latvia with The Innovative Ingredient Lactium® – Against E...

                            Details : GoRelax (lactium), specially patented cow’s milk protein split, has shown that this rotein improves sleep and is a natural anti-anxiety agent that helps reduce signs of stress.

                            Brand Name : GoRelax Day

                            Molecule Type : Small molecule

                            Upfront Cash : Not Applicable

                            March 26, 2020

                            Lead Product(s) : Lactium,Ginseng Extract,Crocus Sativus

                            Therapeutic Area : Neurology

                            Highest Development Status : Approved

                            Sponsor : University of Lorraine

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            Silvanols

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            04

                            Silvanols

                            Latvia
                            2024 ACI Convention
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Tabebuia Avellandae Extract,Olea Europea Extract,Zinc Glycinate

                            Therapeutic Area : Infections and Infectious Diseases

                            Study Phase : Approved

                            Sponsor : Not Applicable

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            DEALS_DEV arrow-down

                            Silvanols Puts Special Emphasis on A Research-Based and Developed Agent to Strengthen the Body’s Defence Abi...

                            Details : GoImmune STRONG (tabebuia avellandae extract), a unique remedy for the season of the common cold, which includes green propolis, tabebuia bark and olive leaf extracts, as well as zinc and selenium.

                            Brand Name : GoImmune STRONG

                            Molecule Type : Small molecule

                            Upfront Cash : Not Applicable

                            February 28, 2020

                            Lead Product(s) : Tabebuia Avellandae Extract,Olea Europea Extract,Zinc Glycinate

                            Therapeutic Area : Infections and Infectious Diseases

                            Highest Development Status : Approved

                            Sponsor : Not Applicable

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            Silvanols

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth